Showing results (1-10 of 35) with videos related to

Sort By:
Pageof 4
The American Journal of Geriatric Psychiatry : Official Journal of the American Association for Geriatric Psychiatry|July 14, 2004
Rivastigmine in Alzheimer disease: efficacy over two yearsGeorge Grossberg, Peter Irwin, Andrew Satlin, et al.
Trials|March 22, 2024
Developing generic templates to shape the future for conducting integrated research platform trialsMadhavi Gidh-Jain, Tom Parke, Franz König, et al.
Therapeutic Innovation & Regulatory Science|May 2, 2018
Clinical Study Design to Assess Both Short- and Long-term Efficacy in Addition to Group Sequential Test on SafetyJiacheng Yuan, Peter Mesenbrink, Jihao Zhou, et al.
Journal of Biopharmaceutical Statistics|September 23, 2015
Seamless Phase IIa/IIb and enhanced dose-finding adaptive designJiacheng Yuan, Herbert Pang, Tiejun Tong, et al.
Trials|March 5, 2021
Systematic review of available software for multi-arm multi-stage and platform clinical trial designElias Laurin Meyer, Peter Mesenbrink, Tobias Mielke, et al.
Obstetrics and Gynecology|February 20, 2010
Zoledronic acid for the prevention of bone loss in postmenopausal women with low bone mass: a randomized controlled trialMichael McClung, Paul Miller, Chris Recknor, et al.
Pharmaceutical Statistics|February 1, 2022
Decision rules for identifying combination therapies in open-entry, randomized controlled platform trialsElias Laurin Meyer, Peter Mesenbrink, Cornelia Dunger-Baldauf, et al.
Clinical Therapeutics|July 6, 2020
The Evolution of Master Protocol Clinical Trial Designs: A Systematic Literature ReviewElias Laurin Meyer, Peter Mesenbrink, Cornelia Dunger-Baldauf, et al.
Artificial Intelligence in Medicine|July 23, 2025
Identifying signatures of image phenotypes to track treatment response in liver diseaseMatthias Perkonigg, Nina Bastati, Ahmed Ba-Ssalamah, et al.
Kidney International|May 30, 2008
Renal safety of annual zoledronic acid infusions in osteoporotic postmenopausal womenSteven Boonen, Deborah E Sellmeyer, Kurt Lippuner, et al.
Pageof 4